Report - HIGHLIGHTS OF PRESCRIBING INFORMATION TAXOTERE ...starting at end of cisplatin infusion (2.4) • • approved patient labeling 2.8 3 5 5.4 HIGHLIGHTS OF PRESCRIBING INFORMATION These

Please pass captcha verification before submit form